Skip to main content

Table 3 The data regarding patients with/without a history of SARSCoV-2 infection

From: Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students—which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?

Side effect Total
N=
ChAdOx1 nCoV-19
N=
Gam-COVID-Vac
N=
BBIBP-CorV
N=
Facial numbness 0.155 (0.020, 1.172)    
Loss of appetite(1) 1.290 (0.944, 1.763) 1.616 (1.052, 2.483)   
Cellulitis warmth and swollen armpit glands 1.565 (0.990, 2.472) 1.810 (1.004, 3.265)   
Fatigue   0.431 (0.222, 0.836)   
Chest pain   1.738 (1.082, 2.794)   
Shortness of breath   0.549 (0.323, 0.935) 1.929 (0.893, 4.166)  
Chills and shiver 1.298 (0.945, 1.784)   2.159 (1.223, 3.809)  
Local pain in the hand    1.700 (0.941, 3.072)  
Insomnia    1.701 (0.965, 2.998)  
Vomiting    0.336 (0.106, 1.063)  
Dysphagia    0.194 (0.045, 0.845)  
Tachycardia    0.187 (0.032, 1.084)  
Faint    4.530 (1.192, 17.209)  
Headache     0.350 (0.119 , 1.031)
Body pain     3.121 (1.105 , 8.819)
  1. OR (95% CI), analysis adjusted for age and gender